The CovClear Rapid Antigen test is a lateral flow assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasal swab specimens directly collected.
$89.99
Out of stock
Why CovClear?
The Safety Seal cap on the CovClear unit permanently contains all bio-exposed test components. Tamper-proof design locks in results with 100% identification certainty. Buffer quantity calibrated for absorbent pad – no excess liquid media.
Features
Simple to use with rapid results in minutes
High sensitivity, specificity and accuracy
Safety advantage with sealed vial protecting against live virus
No reader or cassette required, reducing cost and waste
Failure to follow the instructions for use may adversely affect test performance and/or invalidate the test result.
Results from antigen testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to determine infection status.
The detection of SARS-CoV-2 nucleocapsid antigen is dependent upon proper specimen collection, handling, storage, and preparation. Failure to observe proper procedures in any one of these steps can lead to incorrect results.
Results from the device should be correlated with the clinical history, epidemiological data and other data available.
False-negative results may occur if the concentration of the target antigen in the clinical specimen is below the detection limits of the device.
There is a higher chance of false negative results with home use tests than with laboratory-based molecular tests. This means that there is a higher chance this test will give you a negative result when you have COVID-19.
The performance of this device has not been assessed in a population vaccinated against COVID-19.